Netflix (NASDAQ: NFLX ) is the best performing stock on the S&P 500 in 2013 -- up more than 135% in four months. It's a different story from a year ago, and the complete opposite of what was happening around summer 2011. Coming up on two years since the complete disaster that was Netflix's policy changes and DVD spinoff, the company has now soared to new heights and is likely to be bound for more. While it was not the actions of any one party, there is an important lesson for businesses and investors to learn. As demonstrated by Reed Hastings, here is how to make a full recovery from a serious case of business idiocy.
Dream come true
For the value-conscious and technological skeptics among us, it was a joyous time when Netflix plunged from its $300-per-share days to near $50.
"We told you! Sky-high valuations have no place in the reality of investing."
The thing is, it wasn't a market correction of Netflix's valuation and an understanding that paying 100 times earnings for a company is completely absurd. It was punishment. When Reed Hastings decided to shed the company's DVD delivery business and push up prices on streaming, nearly everybody got ticked off. Eight hundred thousand subscribers fled in the fourth quarter of 2011, according to a recent New York Times article. It wasn't a quick lashing, either, as the stock shed value for more than a year and Hastings was lambasted again and again for poor leadership skills. He took the criticism graciously and admitted quickly the errors of his ways. That was step one.
Top Income Stocks To Invest In Right Now: Athlon Energy Inc (ATHL)
Athlon Energy Inc., incorporated on April 1, 2013, is an independent exploration and production company. The Company is a holding company and its sole assets are controlling equity interests in Athlon Holdings LP and its subsidiaries. The Company is focused on the acquisition, development and exploitation of unconventional oil and liquids-rich natural gas reserves in the Permian Basin. The Permian Basin spans portions of Texas and New Mexico and consists of three primary sub-basins: the Delaware Basin, the Central Basin Platform and the Midland Basin. The Company�� properties are located in the Midland Basin. Its drilling activity is focused on the vertical development of stacked pay zones, including the Spraberry, Wolfcamp, Cline, Strawn, Atoka and Mississippian formations, which it refers to collectively as the Wolfberry play. The Company's acreage position was 124,925 gross at May 31, 2013, which it grousp into three primary areas based on geographic location within the Midland Basin: Howard, Midland and Other and Glasscock. As of April 30, 2013, the Company operated up to eight vertical drilling rigs and has drilled 218 gross operated vertical Wolfberry wells. In February 2014, Athlon Energy Inc announced that subsidiary, Athlon Holdings LP completed the acquisition of certain oil and natural gas properties and related assets in the Midland Basin of West Texas.
As of March 15, 2013, there were 478 total rigs operating in the Permian Basin. The Company�� properties are located within the Midland Basin in areas with approximately 3,000 feet to 4,000 feet of stacked pay zones. Its vertical drilling program is targeting the Spraberry, Wolfcamp, Cline, Strawn, Atoka and Mississippian formations.
Howard
The Company operates four rigs in this area. As of May 31, 2013, the Company had 69,661 gross acres and an inventory of 1,577 gross (1,140 net) identified vertical drilling locations on 40-acre spacing and an additional 1,741 gross identified vertical drilling ! locations on 20-acre spacing. As of April 30, 2013, it had identified 506 gross horizontal drilling locations consisting of 147 gross Wolfcamp A locations, 172 gross Wolfcamp B locations, 25 gross Wolfcamp C locations, 111 gross Cline locations and 51 gross Mississippian locations.
Midland and Other
The Company operates two rigs in this area. As of May 31, 2013, the Company had 36,694 gross acres and an inventory of 424 gross (390 net) identified vertical drilling locations on 40-acre spacing and an additional 463 gross (414 net) identified vertical drilling locations on 20-acre spacing. As of April 30, 2013, it has identified 352 gross horizontal drilling locations consisting of 64 gross Wolfcamp A locations, 125 gross Wolfcamp B locations, 97 gross Wolfcamp C locations and 66 gross Cline locations.
Glasscock
The Company operates one rig in this area. As of May 31, 2013, it had 18,570 gross net acres and an inventory of 297 gross (267 net) identified vertical drilling locations on 40-acre spacing and an additional 400 gross identified vertical drilling locations on 20-acre spacing. As of April 30, 2013, it had identified 232 gross horizontal drilling locations consisting of 54 gross Wolfcamp A locations, 58 gross Wolfcamp B locations, 58 gross Wolfcamp C locations and 62 gross Cline locations.
Advisors' Opinion:- [By Matt Jarzemsky var popups = dojo.query(".socialByline .popC"); popups.forEach]
The drillers considered to be Parsley�� closest peers include Diamondback Energy Inc.(FANG), which has seen its shares rally 38% so far this year through Thursday. Athlon Energy Inc.(ATHL), another similar company, is up 43% this year and 116% since its August IPO.
Top 5 Performing Stocks To Watch For 2014: SanDisk Corporation(SNDK)
Sandisk Corporation designs, develops, and manufactures NAND flash memory storage solutions that are used in various consumer electronics products. The company offers removable cards under the SanDisk Ultra, SanDisk Extreme, and SanDisk Extreme PRO brands; embedded products under the iNAND brand; universal serial bus (USB) flash drives under the Cruzer brand; digital media players under the Sansa brand; solid state drives under the Lightning brand; and wafers and memory components. Its removable card products are used in a range of consumer electronics devices, including mobile phones, digital cameras, gaming devices, and laptop computers; and embedded flash products are used in mobile phones, tablets, ultrabooks, eReaders, global positioning system devices, gaming systems, imaging devices, and computing platforms. The company also provides high-capacity storage solutions, such as solid-state drives that are used in lieu of hard disk drives. It offers its products to the m obile phone, consumer electronics, and computing end markets through original equipment manufacturers, distributors, and retail sales channels in the Americas, the Asia Pacific, Europe, the Middle East, Africa, and Japan. The company was formerly known as SunDisk Corporation and changed its name to SanDisk Corporation in August 1995. SanDisk Corporation was founded in 1988 and is headquartered in Milpitas, California.
Advisors' Opinion:- [By Rex Crum]
SanDisk (SNDK) �shares climbed more than 9% to close at $82.99 a day after the memory and storage-chipmaker reported upbeat quarterly sales and earnings.
- [By Anna Prior]
SanDisk Corp.(SNDK) said its first-quarter earnings jumped 62% as the flash-memory maker reported a rise in revenue. Adjusted earnings and revenue topped Wall Street’s expectations. Shares rose 6.3% to $80.64 premarket.
- [By WALLSTCHEATSHEET]
SanDisk provides valuable and essential data storage solutions that engage with many technology products used and increasing rates by consumers and companies worldwide. The stock has been on a powerful surge higher that has led it to a critical price level. Over most of the last four quarters, earnings and revenue figures have declined, however, investors have been upbeat about earnings announcements. Relative to its peers and sector, SanDisk has been a year-to-date performance leader. Look for SanDisk to OUTPERFORM.
Top 5 Performing Stocks To Watch For 2014: BioCryst Pharmaceuticals Inc.(BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina.
Advisors' Opinion:- [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated
- [By Jon C. Ogg]
BioCryst�Pharmaceuticals Inc. (NASDAQ: BCRX) was started as Outperform with a $7 to $9 price target range at Wells Fargo.
Canadian Pacific Railway Ltd. (NYSE: CP) was upgraded to Outperform from Neutral and the price target was raised to $144 from $139 at Credit Suisse.
- [By Monica Gerson]
BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.
- [By John Udovich]
While the Twitter IPO has been grabing everyone�� attention, biotech IPOs continue to dominate both biotech and IPO news with Karyopharm Therapeutics Inc (NASDAQ: KPTI) going public yesterday and�Relypsa (NASDAQ: RLYP), TetraLogic Pharmaceuticals (NASDAQ: TLOG), Vital Therapies (NASDAQ: VTL) and Xencor (NASDAQ: XNCR) filing to go public in the near future�(despite the sector producing some�ugly charts�for the month of October) plus�another small cap called TNI BioTech (OTCMKTS: TNIB) has also been producing a steady flow of news:
Karyopharm Therapeutics Debuts. Yesterday, small cap Karyopharm Therapeutics, which is working on a drug that aids the body�� natural tumor-suppressing proteins,�debuted at the top of�its range to raise $109 million in an upsized�offering of 6.8 million shares at $16 apiece with shares closing at $16.81. It should be noted that Karyopharm Therapeutics��lead drug candidate (Selinexor) is in early-stage clinical trials�and the company lost�lost nearly $12.5 million on revenue of $366,000 during the first six months of this year. Biotech IPOs by Region. On an interesting note, Luke Timmerman, the National Biotech Editor of Xconomy, has written a�good�article tracking biotech or life sciences IPOs by region. By his count, Boston is home to eight of the 45 (18%) of the life sciences IPOs this year (its companies have also�raised the most money - about $770 million)�plus�the New York/northern New Jersey region is also home to�eight. San Diego�came in third with six IPOs followed by San Francisco with five while only five of the 45 biotech IPOs�came from outside the�US (Three from Israel and two from Europe). However, the above figures may change as by his account, there are 15 additional biotech companies in line to go public. More Biotechs Set IPO Terms. The small cap biotech space is about to be joined by a few new additions as a couple of biotechs file to go public�over the past�week or so: Relypsa, which is d
Top 5 Performing Stocks To Watch For 2014: AutoCanada Inc (ACQ)
AutoCanada Inc. (AutoCanada) is a multi-location automobile dealership groups. As of December 31, 2011, the Company operated 24 franchised dealerships in British Columbia, Alberta, Manitoba, Ontario, New Brunswick and Nova Scotia. During the year ended December 31, 2011, its dealerships sold approximately 28,000 vehicles and processed approximately 300,000 service and collision repair orders in its 333 service bays. As of December 31, 2011, it was authorized to sell through its dealerships the vehicle brands, which include Chrysler, Dodge, Jeep, Ram, Fiat, Hyundai, Nissan, Infiniti, Volkswagen, Mitsubishi and Subaru. In addition, it sells a range of used vehicles. In November 2011, the Company acquired assets of two dealerships. In January 2013, the Company purchased the assets of a Volkswagen dealership known as People's Automotive Ltd. Advisors' Opinion:- [By Greg Quinn]
AutoCanada Inc. (ACQ), the country�� largest publicly traded chain of car dealerships, is using sales of trucks to Alberta oil workers to fund higher dividends and buy out competitors.
No comments:
Post a Comment